EyePoint Pharmaceuticals, Inc. Stock Agreements
10 Contracts & Agreements
- EyePoint Pharmaceuticals, Inc. Amendment No 2. to 2019 Employee Stock Purchase Plan (Filed With SEC on June 21, 2024)
- Form of Stock Option Award for Inducement Grants to executive officer pursuant to the 2023 LTIP (Filed With SEC on March 8, 2024)
- EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan, as amended (Filed With SEC on June 24, 2021)
- EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 28, 2019)
- Stock Option Award Agreement, dated August 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and John Weet (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated August 1, 2018, by and between EyePoint Pharmaceuticals, Inc. and David Price (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum (Filed With SEC on November 9, 2018)
- Form of Stock Option Award Agreement for Inducement grants to executive officers (Filed With SEC on September 18, 2018)
- Nonstatutory Stock Option Inducement Award (Filed With SEC on November 8, 2016)